Trade Mark Journal No.2026/038 18 September 2026

UK00004439670 2 September 2026 (5)

AREXERA THERAPEUTICS

International priority date claimed: 6 August 2026 (United States of America) (50035726)

Class 5: Pharmaceutical preparations, namely, RNA therapeutics for the treatment of neurodegenerative diseases; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of human diseases; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of neurological diseases and disorders; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of pain; Pharmaceutical preparations, namely, RNA therapeutics for the treatment diseases of the central nervous system.

Atalanta Therapeutics, Inc.

Representative: HGF Limited